NO984949L - Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder - Google Patents

Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder

Info

Publication number
NO984949L
NO984949L NO984949A NO984949A NO984949L NO 984949 L NO984949 L NO 984949L NO 984949 A NO984949 A NO 984949A NO 984949 A NO984949 A NO 984949A NO 984949 L NO984949 L NO 984949L
Authority
NO
Norway
Prior art keywords
compounds
treatment methods
preparations containing
carbapenem antibacterial
antibacterial compounds
Prior art date
Application number
NO984949A
Other languages
English (en)
Norwegian (no)
Other versions
NO984949D0 (no
Inventor
Robert R Wilkening
Ronald W Ratcliffe
Timothy A Blizzard
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9609741.5A external-priority patent/GB9609741D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO984949D0 publication Critical patent/NO984949D0/no
Publication of NO984949L publication Critical patent/NO984949L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO984949A 1996-04-24 1998-10-23 Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder NO984949L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1618496P 1996-04-24 1996-04-24
GBGB9609741.5A GB9609741D0 (en) 1996-05-10 1996-05-10 Carbapenem antibacterial compounds compositions containing such componds and methods of treatment
PCT/US1997/006626 WO1997040048A1 (fr) 1996-04-24 1997-04-21 Composes antibacteriens a base de carbapenem, compositions contenant de tels composes et methodes de traitement

Publications (2)

Publication Number Publication Date
NO984949D0 NO984949D0 (no) 1998-10-23
NO984949L true NO984949L (no) 1998-12-21

Family

ID=26309297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984949A NO984949L (no) 1996-04-24 1998-10-23 Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder

Country Status (31)

Country Link
EP (1) EP0906313B1 (fr)
JP (1) JP3176068B2 (fr)
KR (1) KR20000010599A (fr)
CN (1) CN1074767C (fr)
AR (1) AR006810A1 (fr)
AT (1) ATE260915T1 (fr)
AU (1) AU707459B2 (fr)
BG (1) BG102949A (fr)
BR (1) BR9708864A (fr)
CA (1) CA2252402C (fr)
CO (1) CO4990968A1 (fr)
CZ (1) CZ340798A3 (fr)
DE (1) DE69727931T2 (fr)
EA (1) EA001296B1 (fr)
EE (1) EE03689B1 (fr)
ES (1) ES2216142T3 (fr)
HK (1) HK1021186A1 (fr)
HR (1) HRP970213A2 (fr)
HU (1) HUP9901778A3 (fr)
ID (1) ID16662A (fr)
IL (1) IL126480A0 (fr)
IS (1) IS4861A (fr)
NO (1) NO984949L (fr)
NZ (1) NZ332183A (fr)
PE (1) PE64298A1 (fr)
PL (1) PL186881B1 (fr)
SK (1) SK283550B6 (fr)
TR (1) TR199802140T2 (fr)
TW (1) TW539677B (fr)
WO (1) WO1997040048A1 (fr)
YU (1) YU46298A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163522B1 (en) 1994-03-02 2007-01-16 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US6406457B1 (en) 1994-03-02 2002-06-18 Scimed Life Systems, Inc. Block copolymer elastomer catheter balloons
US5908936A (en) * 1997-05-13 1999-06-01 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
EP0981522A1 (fr) * 1997-05-13 2000-03-01 Merck & Co., Inc. Procede de synthese pour composes intermediaires de carbapenem
US6140318A (en) 1997-10-23 2000-10-31 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2306698A1 (fr) * 1997-10-23 1999-04-29 Merck & Co., Inc. Composes antibacteriens carbapenems, compositions contenant ces composes et methodes de traitement
CA2306565A1 (fr) * 1997-10-23 1999-04-29 Merck & Co., Inc. Composes antibacteriens de la classe des carbapenemes, compositions et procedes de traitement
US6271222B1 (en) * 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
JP2002518402A (ja) * 1998-06-17 2002-06-25 メルク エンド カムパニー インコーポレーテッド カルバペネム中間体の合成方法、及び製造された化合物
WO1999066927A1 (fr) * 1998-06-25 1999-12-29 Merck & Co., Inc. Composes antibacteriens a base de carbapenem, compositions renfermant ces composes et methodes therapeutiques
US6291448B1 (en) * 1998-06-25 2001-09-18 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment
US7672747B2 (en) 2000-03-30 2010-03-02 Lam Research Corporation Recipe-and-component control module and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
US5451579A (en) * 1994-02-15 1995-09-19 Merck & Co., Inc. 1-β-methyl-carbapenem, compositions containing same and methods of use

Also Published As

Publication number Publication date
EE9800355A (et) 1999-04-15
CO4990968A1 (es) 2000-12-26
EP0906313B1 (fr) 2004-03-03
HRP970213A2 (en) 1998-06-30
ID16662A (id) 1997-10-30
DE69727931T2 (de) 2005-04-14
TR199802140T2 (xx) 1999-01-18
WO1997040048A1 (fr) 1997-10-30
AU2462997A (en) 1997-11-12
IS4861A (is) 1998-10-06
PL186881B1 (pl) 2004-03-31
JP3176068B2 (ja) 2001-06-11
NZ332183A (en) 2000-05-26
TW539677B (en) 2003-07-01
DE69727931D1 (de) 2004-04-08
SK145498A3 (en) 1999-10-08
AR006810A1 (es) 1999-09-29
BR9708864A (pt) 1999-08-03
CZ340798A3 (cs) 1999-03-17
CA2252402A1 (fr) 1997-10-30
JPH11508279A (ja) 1999-07-21
BG102949A (bg) 1999-10-29
PE64298A1 (es) 1998-10-30
CN1074767C (zh) 2001-11-14
EA001296B1 (ru) 2000-12-25
AU707459B2 (en) 1999-07-08
EE03689B1 (et) 2002-04-15
HUP9901778A3 (en) 2000-06-28
CN1222912A (zh) 1999-07-14
SK283550B6 (sk) 2003-09-11
HK1021186A1 (en) 2000-06-02
YU46298A (sh) 2000-03-21
EP0906313A1 (fr) 1999-04-07
PL329376A1 (en) 1999-03-29
CA2252402C (fr) 2002-12-24
ES2216142T3 (es) 2004-10-16
EA199800949A1 (ru) 1999-04-29
HUP9901778A2 (hu) 1999-09-28
NO984949D0 (no) 1998-10-23
IL126480A0 (en) 1999-08-17
ATE260915T1 (de) 2004-03-15
KR20000010599A (ko) 2000-02-15

Similar Documents

Publication Publication Date Title
ZA973105B (en) Compounds and methods for the selective treatment of cancer and bacterial infections.
DE59406123D1 (de) Haarbehandlungsmittel
NO983266D0 (no) Distribuert Behandling
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO984431L (no) FremgangsmÕte for behandling av smerte
TR199501053A2 (tr) Tedavide yararli spiro-azabisiklik bilesikler.
DE69433434D1 (de) Sterilisationstuchsystem
ZA973487B (en) Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment.
NO932996D0 (no) Utvendig kateter, applikator og fremgangsmaate for bruken
NO944464D0 (no) Framgangsmåte for sikker kommunikasjon
NO984949D0 (no) Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder
DE19681419T1 (de) Behandlungssystem
ID17723A (id) Senyawa untuk pengobatan
NO983263D0 (no) Distribuert behandling
IS4789A (is) Meðferðarefnasambönd
NO984446D0 (no) FremgangsmÕte for behandling av smerte
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
NO961733D0 (no) Fremgangsmåte for desinfisering og törking
ID16924A (id) Metode perlakuan poliolefin
EP1021445A4 (fr) Compositions antibacteriennes de carbapenem, preparations les contenant et methodes de traitement
EP0977567A4 (fr) Composes antibacteriens de carbapenem, compositions contenant lesdits composes et methodes de traitement
EP1027352A4 (fr) Composes antibacteriens de la classe des carbapenemes, compositions et procedes de traitement
EP1032384A4 (fr) Composes antibacteriens, compositions et procedes de traitement aux carbapenemes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application